Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metaraminol for prevention of hypotension during ICU tracheal intubation in sepsis
RBR-42z99fPhase 4Withdrawn
- Sponsor
- Fernando da Silveira
- Start
- Mar 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of metahydroxylamine in sepsis (2 arms), sponsored by Fernando da Silveira. Primary endpoint: Peri-intubation blood pressure and heart rate monitoring. Planned start Mar 2019; status: withdrawn.
02
Drugs
metahydroxylamine
03
Conditions
sepsis
Beyond the preview
Go deeper on RBR-42z99f.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-42z99f.